Merrimack Pharmaceuticals (MACK)

Latest Trade:   $5.28 0.00 (0.0%)
$5.28
IPO News
IPO Performance
  • -13.7%
  • -12.6%
  • -24.6%
IPO Profile
  • 03/28/12
  • $7.00
  • 14.3 mm
  • As of 3/26/12. Previous terms (1/13/12): 16.7 million shares at $7-$9. Total Shares figure excludes 12,821,882 shares based on options that may eventually become dilutive to shareholders once MACK turns profitable.
  • J.P. Morgan
  • BofA Merrill Lynch

  • All Underwriters
Business
  • Uses its Network Biology system to discover and develop cancer treatments.
  • Health-Drugs
  • 218
  • 1993
MACK Daily
 
Corporate Data
  • One Kendall Square, Suite B7201
    Cambridge, MA
  • (617) 441-1000
  • www.merrimackpharma.com